Myrta Atiles | AIChE

Myrta Atiles

Executive Director
Amgen

Myrta Atiles joined Amgen in 2003.  She is currently the Plant Manager Executive Director of Drug Product filling operations at Juncos.  Prior to this role she was the Executive Director of Process Development for Drug Product including Oral dosage form, Formulation, Filling, Inspection, Device Assembly and Final Package Product at AML.  Moreover, she was the Amgen lead for the collaboration with Eli Lilly on the manufacture of two antibodies for the treatment of Covid-19.  

Over her time at Amgen, she has held several positions of increasing responsibility including Global Operations Lead for oncology programs, Process Development Director responsible to support the Oral Dosage and Fill & finish operations and Senior Scientist for Drug Substance in Amgen’s facility located in Puerto Rico. Her scope included Technology Transfer for New Product Introductions, Commercial Support, Productivity Capital Projects, Cleaning and Process Validation. Over the years, Myrta have led over 50 programs to the site from Drug Substance to Drug Product including, more than 20 new product introductions, facility start-ups and implementation of new technology.  She pioneered the platform standardization for the filling technology at the Amgen network and implementation of Artificial Intelligence for automatic inspection.

Myrta also served as the president of the Amgen’s woman diversity group called WE2 from where she created a program that promotes, networking, professional development and community service and is a member of the Puerto Rico Manufacturing Association woman chapter. 

Prior to joining Amgen in 2003, Myrta held several Research and Development Scientist positions at Cellular Genomics (CT) and at Third Wave Technologies (WI) where for the latter, in addition to be a research scientist, she partnered with marketing as part of the company Road Show Strategy across several countries.

Myrta has a bachelor’s degree in industrial microbiology from the University of Puerto Rico, Mayagüez, and a master’s degree in Bacteriology and Molecular Biology from the University of Wisconsin, Madison.